Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
Carole Parsons(Queen's University Belfast), Carmel Hughes(Queen's University Belfast), Stéphanie Ward(Monash University), Peter Passmore(Queen's University Belfast), Clement T. Loy(The University of Sydney), Bernadette McGuinness(Queen's University Belfast), Wei Yin Lim(Ministry of Health)
Cited by 43
Related Papers
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774